| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Kelch-like ECH-associated protein 1|Cytosolic inhibitor of Nrf2|INrf2|Kelch-like protein 19|KEAP1|INRF2|KIAA0132|KLHL19 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human KEAP1 (kelch-like ECH-associated protein 1) is a molecular target commonly studied in cancer and metabolism research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of KEAP1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of KEAP1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
KEAP1 (kelch-like ECH-associated protein 1) may also be referenced as Kelch-like ECH-associated protein 1, Cytosolic inhibitor of Nrf2, and INrf2 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how KEAP1 relates to tumor microenvironment biology, cell proliferation and apoptosis, metastasis and invasion pathways, and angiogenesis and immune-oncology mechanisms in cancer and metabolism research.
- Interpreting shifts in KEAP1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
KEAP1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with cancer and metabolism studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Antioxidant Defense Expressed as Glutathione Status and Keap1-Nrf2 System Action in Relation to Anthropometric Parameters and Body Composition in Young Women with Polycystic Ovary Syndrome
IF: 7.675 Journal: Antioxidants Cited Date: 2023-03-31
Oxidative Stress Indicated by Nuclear Transcription Factor Nrf2 and Glutathione Status in the Blood of Young Children with Autism Spectrum Disorder: Pilot Study
IF: 6 Journal: Antioxidants Author: Department of Screening Tests and Metabolic Diagnostics, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland Cited Date: 2025-03-14
High KEAP1, NRF2 and Low HO-1 Serum Levels in Children with Autism
IF: 0.707 Journal: Archives of Neuropsychiatry Cited Date: 2020-10-16
Low HO-1 and high KEAP1 serum levels in children with attention deficit hyperactivity disorder: the first clinical study.
IF: 0.206 Journal: Anadolu Psikiyatri Dergisi - Anatolian Journal of Psychiatry Cited Date: 2020-04-20
Relationship Between Oxidative Stress, Tau Level and Antioxidant Mechanisms of the KEAP-1/NRF-2/HO-1 in Children with Hydrocephalus
IF: Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cited Date: 2021-12-02